About Human Papillomavirus (HPV) Infection Vaccination
- Notice Regarding Human Papillomavirus (HPV) Infection Vaccination
- About Human Papillomavirus (HPV) Infection Vaccination
- Target Age
- Number of vaccinations
- Vaccination Interval
- About the Pre-examination Questionnaire
- National Information on HPV Vaccination
- Vaccination Location
- Belongings
- Post-Vaccination Precautions
- Description for receiving the Human Papillomavirus Vaccination
- About the Health Damage Relief System
- Regarding Vaccination When the Parent or Guardian is Not Accompanying
Notice Regarding Human Papillomavirus (HPV) Infection Vaccination
Regarding the Vaccines Used for Human Papillomavirus (HPV) Vaccination from April 1, 2026
From April 1, 2026, the only vaccine available for Human Papillomavirus (HPV) vaccination will be the 9-valent vaccine (Silgard 9).
The bivalent vaccine (Cervarix) and the quadrivalent vaccine (Gardasil) will no longer be available for use from April 1, 2026.
In fiscal year 2013, the human papillomavirus vaccination was added to the regular vaccination schedule.
Cervical cancer is a type of cancer that occurs in the cervix, which is the entrance to the uterus. In Japan, approximately 10,000 people are diagnosed with it each year, and about 3,000 people die from this disease annually.
Most cervical cancers are caused by infection with HPV (human papillomavirus) through sexual intercourse, and it is more common in younger generations, with a recent surge in cases among those in their 20s and 30s.
Vaccination against human papillomavirus infection and regular cervical cancer screenings are effective in preventing the onset of cancer.
If you wish to receive the vaccination, please make sure to understand the effects and side effects before getting vaccinated.
About Human Papillomavirus (HPV) Infection Vaccination
The vaccine used for vaccination against human papillomavirus (HPV) infection is the "9-valent vaccine (Cervarix 9)".
For details on the vaccination intervals, number of doses, etc., please see below.
Target Age
- Currently, girls aged equivalent to 6th grade of elementary school to 1st year of high school as of the vaccination date
Number of vaccinations
3 times or 2 times
Note: The number of doses required to complete the vaccination varies depending on the age at which vaccination is started.
For more details, please check below.
Vaccination Interval
(1) 9-valent vaccine (Gardasil 9) ... when receiving the first dose between the 6th grade of elementary school and up to 15 years old.
Standard Vaccination Interval
Second time: 6 months after the first time
If vaccination cannot be done at the standard interval
Administer the first and second doses with an interval of at least 5 months.
- Note 1: If the interval between the first and second vaccinations is less than 5 months, a third vaccination is required.
- Note 2: As mentioned above, in addition to the vaccination method that is completed with three doses, it is now possible to complete the vaccination with two doses.
(2) 9-valent vaccine (Gardasil 9) ... when receiving the first dose after turning 15 years old
Standard Vaccination Interval
- Second dose: 2 months after the first dose
- 3rd time: 6 months after the 1st vaccination
If vaccination cannot be done at the standard interval
Administer the first and second doses with an interval of more than one month, and the second and third doses with an interval of more than three months.
About the Pre-examination Questionnaire
You can use the current health questionnaire as is.
Note: If you do not have the vaccination pre-examination form due to reasons such as moving, you can receive the pre-examination form by presenting your vaccination history with the Maternal and Child Health Handbook at the Inagi City Health Center.
National Information on HPV Vaccination
-
Human Papillomavirus Infection - Cervical Cancer (Cervical Cancer) and HPV Vaccine (Ministry of Health, Labor and Welfare)(External Link)
-
Q&A about HPV Vaccine (Ministry of Health, Labor and Welfare)(External Link)
HPV vaccination is not mandatory.
In addition to checking the Ministry of Health, Labor and Welfare website, please consult with the medical institutions administering the vaccine to ensure you have a thorough understanding of the vaccine's safety and effectiveness before getting vaccinated.
Vaccination Location
Some medical institutions may require reservations, so please check in advance.
Belongings
- Identity Verification Documents
- Maternal and Child Health Handbook (a record of vaccinations)
- Pre-examination Questionnaire
Note: If you do not have a pre-examination form due to relocation, please contact the Health Center or each medical institution.
Post-Vaccination Precautions
- After vaccination, there may be fainting due to pain from the injection or psychogenic reactions. To prevent falls due to fainting, a Parent or Guardian or healthcare professional should accompany you by holding your arm during movement after the injection, and please sit in a place where you can rest your weight for about 30 minutes after vaccination.
- If you experience any abnormalities such as high fever or convulsions after vaccination, please seek a doctor's diagnosis promptly.
- Pay attention to your health for one week after vaccination. If you notice significant swelling or feel unwell after the vaccination, please consult a doctor. The vaccination for human papillomavirus infection is administered as an intramuscular injection, so you may experience muscle pain for about a week after the injection.
- Keep the vaccination site clean. Bathing is not a problem, but do not rub the vaccination site.
Description for receiving the Human Papillomavirus Vaccination
If you wish to receive the vaccination, please read and understand the "Explanation for Receiving the Human Papillomavirus Infection Vaccination" below, and consult with a doctor before getting vaccinated.
About the Health Damage Relief System
- If health damage occurs due to adverse reactions caused by regular vaccinations, such as requiring treatment at a medical institution or hindering daily life, you can receive benefits based on the Vaccination Law.
- Depending on the extent of health damage, there are categories for Medical Expenses, medical allowances, child-rearing pensions for disabled children, disability pensions, one-time death benefits, and Funeral Services, with amounts specified by law being provided.
- However, if the health damage was caused by the vaccination or by another factor (such as an infection that occurred before or after the vaccination or other causes), the causal relationship will be discussed at a national review committee composed of experts in various fields such as vaccination, infectious disease medicine, and law. Benefits can be received if it is recognized as being caused by the vaccination.
- If you need to apply for benefits, please contact the examining physician or the Health Division of Inagi City.
Note: For more details, please visit the Ministry of Health, Labor and Welfare website.
Regarding Vaccination When the Parent or Guardian is Not Accompanying
- If you wish to receive the vaccination without the accompaniment of a Parent or Guardian, please be sure to bring the "Consent Form for Receiving the Human Papillomavirus Vaccination."
- However, this is limited to those aged 13 and over as of the vaccination date.
To view the PDF file, you need "Adobe(R) Reader(R)". If you do not have it, please download it for free from Adobe website (new window).
This page is managed by the Health Division, Welfare Department
112-1 Momura, Inagi City, Tokyo 206-0804 (Inside Inagi City Health Center)
Phone number: 042-378-3421 Fax number: 042-377-4944
Contact the Health Division, Welfare Department of Inagi City



















